|
| |
 |
| ANAGRID 0.5 |
אנגריד 0.5 |
|
|
|
|
| כן, יש ללחוץ כאן לפירוט |
בסל הבריאות?: |
|
|
| Anagrid 0.5 is indicated for the reduction of an increased platelet number and associated clinical symptoms in high risk patients with Essential Thrombocythemia. High risk patient with essential thrombocythemia show one or more following symptoms: Age >= 60, Platelet count >= 1.000.000/ ?l, Increase of platelet count >= 300.000/ ?l within 3 month, Severe thrombohaemorrhagic or ischaemic symptoms in anamnesis, Vascular risk factors. |
התוויה מאושרת: |
|
| CAPSULES |
דרך מתן:
|
|
| RAFA LABORATORIES LTD |
בעל רישום: |
|
| 148-64-33344-00 |
מספר רישום:
|
|
|
|
|
|
|
 |
INFO ON THE WEB |
מידע ברשת |
|
|
|
|
|
